EP1177788A2 — Pharmaceutical composition of fluoxetin in coated dispersible tablets and process for its manufacture
Assigned to Laboratorios Cinfa SA · Expires 2002-02-06 · 24y expired
What this patent protects
Pharmaceutical composition of fluoxetin in coated dispersible tablets and process for its manufacture, of the type of composition used as an antidepressant which contains fluoxetin hydrochloride as the active ingredient and is presented in the form of a dispersible tablet in whic…
USPTO Abstract
Pharmaceutical composition of fluoxetin in coated dispersible tablets and process for its manufacture, of the type of composition used as an antidepressant which contains fluoxetin hydrochloride as the active ingredient and is presented in the form of a dispersible tablet in which the active ingredient is micronised and its weight lies between eight and nine percent (8-9%) of the total weight of the core of the composition, while the moisture content of the core of the composition lies between three and four percent (3-4%) and the core is coated with a film coating comprising a water-soluble film-producing agent and a plasticiser, this film coating representing around one percent (1%) of the total weight of the tablet.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.